Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06320808 · ClinicalTrials.gov registry record · NA
Evaluating FDA's Proposed Patient Medication Information Handout
A NA study, sponsored by Carnegie Mellon University.
- Completed
- Registry status
- NA
- Development phase
- 330
- Enrollment target
NCT06320808: Completed NA study, sponsored by Carnegie Mellon University.
NCT06320808 is a NA study that has completed, run by Carnegie Mellon University. The registered enrollment target is 330 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06320808, a NA study, has completed, sponsored by Carnegie Mellon University.
- COMPLETED
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
Study Summary
The goal of this study is to assess how useful the proposed one-page FDA-template PMI is to potential users. The main questions it aims to answer are: How does the proposed one-page FDA-template PMI compare with the current drug information insert in terms of usefulness and comprehension? and How does the proposed one-page FDA-template PMI compare with a revision adding drug benefit information? Participants will randomized to review one of three patient medication information sheets and then asked questions related to usefulness and comprehension.
Primary Outcome
Single question with a 5-point likert scale response for "How easy or difficult was it to read the medication information guide about \[drug\]?" Minimum score is 1; Maximum score is 5. A higher score represents higher perceived usefulness.
Interventions
- OTHER FDA template PMI
- OTHER Decision Critical PMI
- OTHER Standard Information
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2024-03-03 |
| Est. Completion | 2025-02-06 |
| Phase | NA |
What the finished NCT06320808 record still lists
NCT06320808 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 3 interventions - of which FDA template PMI is the first listed.
NCT06320808 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06320808 about?
NCT06320808 is a clinical study titled "Evaluating FDA's Proposed Patient Medication Information Handout". The goal of this study is to assess how useful the proposed one-page FDA-template PMI is to potential users. The main questions it aims to answer are: How does the proposed one-page FDA-template PMI compare with the current drug information insert in terms of usefulness and comprehension? and Ho...
What is the current status of trial NCT06320808?
This trial is currently completed. It is a NA study. The enrollment target is 330 participants. The study started on 2024-03-03. Estimated completion is 2025-02-06.
What interventions are being tested in trial NCT06320808?
The interventions under investigation include: FDA template PMI (OTHER), Decision Critical PMI (OTHER), Standard Information (OTHER).
Who is sponsoring clinical trial NCT06320808?
This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06320808's enrollment target sits among peer trials
330 307th of 2000 higher than 1,693 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI